105 related articles for article (PubMed ID: 21782781)
21. Zinc pyrithione-mediated activation of voltage-gated KCNQ potassium channels rescues epileptogenic mutants.
Xiong Q; Sun H; Li M
Nat Chem Biol; 2007 May; 3(5):287-96. PubMed ID: 17435769
[TBL] [Abstract][Full Text] [Related]
22. Differential tetraethylammonium sensitivity of KCNQ1-4 potassium channels.
Hadley JK; Noda M; Selyanko AA; Wood IC; Abogadie FC; Brown DA
Br J Pharmacol; 2000 Feb; 129(3):413-5. PubMed ID: 10711337
[TBL] [Abstract][Full Text] [Related]
23. Thallium Flux Assay for Measuring the Activity of Monovalent Cation Channels and Transporters.
Weaver CD
Methods Mol Biol; 2018; 1684():105-114. PubMed ID: 29058187
[TBL] [Abstract][Full Text] [Related]
24. Isoform-specific prolongation of Kv7 (KCNQ) potassium channel opening mediated by new molecular determinants for drug-channel interactions.
Gao Z; Zhang T; Wu M; Xiong Q; Sun H; Zhang Y; Zu L; Wang W; Li M
J Biol Chem; 2010 Sep; 285(36):28322-32. PubMed ID: 20584905
[TBL] [Abstract][Full Text] [Related]
25. Development and validation of a cell-based high-throughput screening assay for TRPM2 channel modulators.
Song Y; Buelow B; Perraud AL; Scharenberg AM
J Biomol Screen; 2008 Jan; 13(1):54-61. PubMed ID: 18057180
[TBL] [Abstract][Full Text] [Related]
26. Profiling diverse compounds by flux- and electrophysiology-based primary screens for inhibition of human Ether-à-go-go related gene potassium channels.
Zou B; Yu H; Babcock JJ; Chanda P; Bader JS; McManus OB; Li M
Assay Drug Dev Technol; 2010 Dec; 8(6):743-54. PubMed ID: 21158688
[TBL] [Abstract][Full Text] [Related]
27. Development and validation of fluorescence-based and automated patch clamp-based functional assays for the inward rectifier potassium channel Kir4.1.
Raphemot R; Kadakia RJ; Olsen ML; Banerjee S; Days E; Smith SS; Weaver CD; Denton JS
Assay Drug Dev Technol; 2013; 11(9-10):532-43. PubMed ID: 24266659
[TBL] [Abstract][Full Text] [Related]
28. A high-throughput screening campaign for detection of ca(2+)-activated k(+) channel activators and inhibitors using a fluorometric imaging plate reader-based tl(+)-influx assay.
Jørgensen S; Dyhring T; Brown DT; Strøbæk D; Christophersen P; Demnitz J
Assay Drug Dev Technol; 2013 Apr; 11(3):163-72. PubMed ID: 23198866
[TBL] [Abstract][Full Text] [Related]
29. A thallium transport FLIPR-based assay for the identification of KCC2-positive modulators.
Zhang D; Gopalakrishnan SM; Freiberg G; Surowy CS
J Biomol Screen; 2010 Feb; 15(2):177-84. PubMed ID: 20086212
[TBL] [Abstract][Full Text] [Related]
30. Design, synthesis and evaluation of substituted piperidine based KCNQ openers as novel antiepileptic agents.
Yang S; Lu D; Ouyang P
Bioorg Med Chem Lett; 2018 Jun; 28(10):1731-1735. PubMed ID: 29706422
[TBL] [Abstract][Full Text] [Related]
31. Homomeric and heteromeric assembly of KCNQ (Kv7) K+ channels assayed by total internal reflection fluorescence/fluorescence resonance energy transfer and patch clamp analysis.
Bal M; Zhang J; Zaika O; Hernandez CC; Shapiro MS
J Biol Chem; 2008 Nov; 283(45):30668-76. PubMed ID: 18786918
[TBL] [Abstract][Full Text] [Related]
32. Rb+ efflux assay for assessment of non-selective cation channel activities.
Liu K; Samuel M; Harrison RK; Paslay JW
Assay Drug Dev Technol; 2010 Jun; 8(3):380-8. PubMed ID: 20085483
[TBL] [Abstract][Full Text] [Related]
33. A real-time screening assay for GIRK1/4 channel blockers.
Walsh KB
J Biomol Screen; 2010 Dec; 15(10):1229-37. PubMed ID: 20938046
[TBL] [Abstract][Full Text] [Related]
34. A novel high-throughput screening assay for HCN channel blocker using membrane potential-sensitive dye and FLIPR.
Vasilyev DV; Shan QJ; Lee YT; Soloveva V; Nawoschik SP; Kaftan EJ; Dunlop J; Mayer SC; Bowlby MR
J Biomol Screen; 2009 Oct; 14(9):1119-28. PubMed ID: 19773585
[TBL] [Abstract][Full Text] [Related]
35. N-(6-chloro-pyridin-3-yl)-3,4-difluoro-benzamide (ICA-27243): a novel, selective KCNQ2/Q3 potassium channel activator.
Wickenden AD; Krajewski JL; London B; Wagoner PK; Wilson WA; Clark S; Roeloffs R; McNaughton-Smith G; Rigdon GC
Mol Pharmacol; 2008 Mar; 73(3):977-86. PubMed ID: 18089837
[TBL] [Abstract][Full Text] [Related]
36. Development of a Novel Cell-Based Assay System for High-Throughput Screening of Compounds Acting on Background Two-Pore Domain K
Kawasaki K; Suzuki Y; Yamamura H; Imaizumi Y
SLAS Discov; 2019 Jul; 24(6):641-652. PubMed ID: 30802418
[TBL] [Abstract][Full Text] [Related]
37. The acrylamide (S)-1 differentially affects Kv7 (KCNQ) potassium channels.
Bentzen BH; Schmitt N; Calloe K; Dalby Brown W; Grunnet M; Olesen SP
Neuropharmacology; 2006 Nov; 51(6):1068-77. PubMed ID: 16904708
[TBL] [Abstract][Full Text] [Related]
38. Cellular HTS assays for pharmacological characterization of Na(V)1.7 modulators.
Trivedi S; Dekermendjian K; Julien R; Huang J; Lund PE; Krupp J; Kronqvist R; Larsson O; Bostwick R
Assay Drug Dev Technol; 2008 Apr; 6(2):167-79. PubMed ID: 18078380
[TBL] [Abstract][Full Text] [Related]
39. High-throughput screening for small-molecule modulators of inward rectifier potassium channels.
Raphemot R; Weaver CD; Denton JS
J Vis Exp; 2013 Jan; (71):. PubMed ID: 23381507
[TBL] [Abstract][Full Text] [Related]
40. Miniaturisation and validation of a cell-based assay for screening of Ca2+ channel modulators.
Tammela P; Vuorela P
J Biochem Biophys Methods; 2004 Jun; 59(3):229-39. PubMed ID: 15165754
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
